Esslingen, Germany

Francesca Blasco

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Basf Aktiengesellschaft. Active years: 2009.



Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francesca Blasco: Innovator in Cytochrome P450 Monooxygenases

Introduction: Francesca Blasco, based in Esslingen, Germany, is a talented inventor known for her significant contributions to the field of biochemistry. With a focus on the innovative development of cytochrome P450 monooxygenases from thermophilic bacteria, her work has important implications for microbiological processes.

Latest Patents: Francesca holds a patent for "Cytochrome P450 monooxygenases consisting of thermophilic bacteria." This invention involves the discovery of novel cytochrome P450 monooxygenases derived from thermophilic bacteria, specifically in the genus sp. The patent encompasses nucleotide sequences encoding these enzymes, their recombinant production, and applications in the microbiological oxidation of organic compounds.

Career Highlights: Throughout her career, Francesca has demonstrated a commitment to advancing scientific knowledge and technology. She works at BASF Aktiengesellschaft, a leading organization in chemical production, where she applies her expertise to further the understanding and utility of monooxygenases in various industrial applications.

Collaborations: Francesca collaborates with esteemed colleagues Bernhard Hauer and Rolf Schmid, both of whom contribute valuable insights and expertise to her research endeavors. This teamwork enhances the innovative potential of their projects and facilitates breakthroughs in the field.

Conclusion: Francesca Blasco's work exemplifies the spirit of innovation in the scientific community. Her patented inventions in the biochemistry of cytochrome P450 monooxygenases position her as a noteworthy inventor, making strides toward sustainable solutions in microbiological applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…